Elizabeth (Lizzy) Doctorov is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s patents and innovations group. She focuses on patent prosecution, primarily in the fields of biotechnology, life sciences, and medical devices. Lizzy also provides support in various matters related to intellectual property counseling, including performance of due diligence and freedom to operate analysis.
Lizzy pursued an undergraduate degree in molecular and cell biology with a focus on neurobiology. During law school, she conducted research on the intersection of law and neuroscience at Harvard Medical School’s Center for Law, Brain, and Behavior under Professor Francis Shen, J.D., PhD.
Lizzy is fluent in Russian.
Elizabeth (Lizzy) Doctorov is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s patents and innovations group. She focuses on patent prosecution, primarily in the fields of biotechnology, life sciences, and medical devices. Lizzy also provides support in various matters related to intellectual property counseling, including performance of due diligence and freedom to operate analysis.
Lizzy pursued an undergraduate degree in molecular and cell biology with a focus on neurobiology. During law school, she conducted research on the intersection of law and neuroscience at Harvard Medical School’s Center for Law, Brain, and Behavior under Professor Francis Shen, J.D., PhD.
Lizzy is fluent in Russian.
- J.D., UC Berkeley School of Law, 2023Business Law Certificate
- B.A., Molecular and Cell Biology, University of California, Berkeley, 2020
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., UC Berkeley School of Law, 2023Business Law Certificate
- B.A., Molecular and Cell Biology, University of California, Berkeley, 2020
- State Bar of California
- U.S. Patent and Trademark Office
Select Representations
- Bolt Medical (laser-based intravascular lithotripsy) in its January 2025 acquisition by Boston Scientific for $600 million upfront and up to $300 million in milestone payments
Select Representations
- Bolt Medical (laser-based intravascular lithotripsy) in its January 2025 acquisition by Boston Scientific for $600 million upfront and up to $300 million in milestone payments
Select Publications
- Author, “Fearless Dining: Mandating Universal Allergen Disclosures on Restaurant Menus,” California Law Review, June 28, 2023
- Co-author, “Genetic Mapping and Biochemical Basis of Yellow Feather Pigmentation in Budgerigars,” 171(2) Cell 427-439, October 5, 2017
Select Publications
- Author, “Fearless Dining: Mandating Universal Allergen Disclosures on Restaurant Menus,” California Law Review, June 28, 2023
- Co-author, “Genetic Mapping and Biochemical Basis of Yellow Feather Pigmentation in Budgerigars,” 171(2) Cell 427-439, October 5, 2017
Diagnostics and Medical Devices
- Medical devices
- Medical imaging
-
Neuroimaging
-
Wearable analyte sensors
Engineering and Advanced Technologies
- Machine learning
- Mechanical engineering
- Microfluidics
Miscellaneous
- Data center cooling solutions
- Digestive health
- External medical accessories
- Internal medical devices
- Magnetic Resonance Imaging (MRI) technology
- Medical waste management systems for hospitals
- Solar
- Surgical robotics
Diagnostics and Medical Devices
- Medical devices
- Medical imaging
-
Neuroimaging
-
Wearable analyte sensors
Engineering and Advanced Technologies
- Machine learning
- Mechanical engineering
- Microfluidics
Miscellaneous
- Data center cooling solutions
- Digestive health
- External medical accessories
- Internal medical devices
- Magnetic Resonance Imaging (MRI) technology
- Medical waste management systems for hospitals
- Solar
- Surgical robotics
- Privacy Policy
- Terms of Use
- Accessibility